![flex type setting philips respironics system one 460p c-flex+ remstar pro flex type setting philips respironics system one 460p c-flex+ remstar pro](https://images.cpap.com/products/philips-respironics/DS450S/respironics-pr-system-pro-hero-shot.jpg)
As part of the plan, the company is replacing the polyester-based polyurethane foam with a different, silicone-based foam. Repairing and Replacing the Recalled Devicesįollowing the recall, Philips Respironics developed a plan to repair or replace recalled CPAP and BiPAP devices. At this time, the agency does not have sufficient information to conclude whether the silicone-based foam being used in the repaired devices poses any risk to patients in the U.S. The FDA is aware that patients have already received devices with silicone-based foam as part of the repair and replace program. The FDA has requested that Philips Respironics retain an independent laboratory to perform additional testing to determine what, if any, potential safety risks may be posed to patients by the silicone-based foam. Similar testing provided by Philips Respironics to the FDA on devices authorized for marketing in the U.S. In response to the recall, the FDA conducted an inspection of a Philips Respironics’ manufacturing facility to determine what may have caused or contributed to the foam issues.ĭuring the manufacturing facility inspection, the FDA obtained additional information, not previously available to the agency, regarding the silicone-based foam used in a singular, similar device marketed outside the U.S., which failed one safety test for the release of certain chemicals of concern, called volatile organic compounds (VOCs). Information Obtained During the 2021 Inspection FDA Safety Communication: Update: Certain Philips Respironics Ventilators, BiPAP, and CPAP Machines Recalled Due to Potential Health Risks: FDA Safety Communication (November 2021).
FLEX TYPE SETTING PHILIPS RESPIRONICS SYSTEM ONE 460P C FLEX+ REMSTAR PRO HOW TO
![flex type setting philips respironics system one 460p c-flex+ remstar pro flex type setting philips respironics system one 460p c-flex+ remstar pro](https://i.ebayimg.com/images/g/0BsAAOSwnZxgC8iq/s-l640.jpg)
The FDA developed this page to address questions about this recall and provide additional resources with more information. FDA inspections are designed to include the review and evaluation of records, staff training, facility operations, medical device production and testing, and the systems in place to ensure product quality. In response to the recall, the FDA recently conducted an inspection of a Philips Respironics’ manufacturing facility to determine what may have caused or contributed to the foam issues and assess adherence to the agency’s quality system regulations. Additionally, the foam damage may get worse in hot and humid settings and by using ozone or ultraviolet (UV) light cleaners or other cleaning methods not recommended by the manufacturer. These issues could potentially result in serious injury, which can be life-threatening, cause permanent impairment, and require medical intervention to prevent permanent injury to users. If this occurs, black pieces of foam, or certain chemicals that are not visible, could be breathed in or swallowed by the person using the device.
![flex type setting philips respironics system one 460p c-flex+ remstar pro flex type setting philips respironics system one 460p c-flex+ remstar pro](https://images.cpap.com/products/philips-respironics/1017453/Remstar_Auto_C-flex_top.jpg)
The polyester-based polyurethane foam used in these medical devices to lessen sound and vibration can break down. In June 2021, Philips Respironics voluntarily recalled certain ventilators, bi-level positive airway pressure (also known as Bilevel PAP, BiPAP, or BPAP), and continuous positive airway pressure (CPAP) machines due to potential health risks.